Nathan Peiffer-Smadja

About Nathan Peiffer-Smadja

Nathan Peiffer-Smadja, With an exceptional h-index of 32 and a recent h-index of 32 (since 2020), a distinguished researcher at Imperial College London, specializes in the field of Medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Multivariate joint model under competing risks to predict death of hospitalized patients for SARS‐CoV‐2 infection

Artificial intelligence in infectious diseases

Dengue, Zika, chikungunya: un état des lieux en France hexagonale

Médecine tropicale: comment mieux se protéger des maladies tropicales?

Enterococcal endocarditis management and relapses

Meningitis infecciosa aguda del adulto

Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial

Identification of a newly emerging second-generation HIV-1 circulating recombinant form (CRF145_0755) among men who have sex with men in China

Nathan Peiffer-Smadja Information

University

Position

Clinical Research Fellow

Citations(all)

5957

Citations(since 2020)

5919

Cited By

926

hIndex(all)

32

hIndex(since 2020)

32

i10Index(all)

59

i10Index(since 2020)

57

Email

University Profile Page

Google Scholar

Nathan Peiffer-Smadja Skills & Research Interests

Medicine

Top articles of Nathan Peiffer-Smadja

Multivariate joint model under competing risks to predict death of hospitalized patients for SARS‐CoV‐2 infection

Biometrical Journal

2024/1

Artificial intelligence in infectious diseases

2024/1/1

Nathan Peiffer-Smadja
Nathan Peiffer-Smadja

H-Index: 13

Dengue, Zika, chikungunya: un état des lieux en France hexagonale

2024/5/2

Nathan Peiffer-Smadja
Nathan Peiffer-Smadja

H-Index: 13

Médecine tropicale: comment mieux se protéger des maladies tropicales?

2024/5/2

Nathan Peiffer-Smadja
Nathan Peiffer-Smadja

H-Index: 13

Enterococcal endocarditis management and relapses

JAC-Antimicrobial Resistance

2024/4

Nathan Peiffer-Smadja
Nathan Peiffer-Smadja

H-Index: 13

Meningitis infecciosa aguda del adulto

2024/3/29

Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial

Clinical Infectious Diseases

2024/3/29

Joe Miantezila Basilua
Joe Miantezila Basilua

H-Index: 3

Nathan Peiffer-Smadja
Nathan Peiffer-Smadja

H-Index: 13

Identification of a newly emerging second-generation HIV-1 circulating recombinant form (CRF145_0755) among men who have sex with men in China

Journal of Infection

2024/3/1

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

Journal of Infection

2024/3/1

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

EClinicalMedicine

2024/3/1

Machine learning to predict antimicrobial resistance: future applications in clinical practice?

2024/2/12

Timothy Miles Rawson
Timothy Miles Rawson

H-Index: 19

Nathan Peiffer-Smadja
Nathan Peiffer-Smadja

H-Index: 13

CARECOS study: Medical students’ empathy as assessed with the CARE measure by examiners versus standardized patients during a formative Objective and Structured Clinical …

Medical Teacher

2024/1/27

Nathan Peiffer-Smadja
Nathan Peiffer-Smadja

H-Index: 13

Association of country income level with the characteristics and outcomes of critically ill patients hospitalized with acute kidney injury and COVID-19

Kidney international reports

2023/8/1

Complicated scarring following mpox infection

British Journal of Dermatology

2023/8

Nathan Peiffer-Smadja
Nathan Peiffer-Smadja

H-Index: 13

Incidence, risk factors and treatment of central nervous system immune reconstitution inflammatory syndrome in non‐HIV patients with tuberculous meningitis: a multicentre …

Internal Medicine Journal

2023/12/8

Implementation of a centralized pharmacovigilance system in academic pan‐European clinical trials: Experience from EU‐Response and conect4children consortia

2023/4

Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA. 1 and BA. 2 COVID-19 treated with sotrovimab or nirmatrelvir

Clinical Microbiology and Infection

2023/4/1

Nathan Peiffer-Smadja
Nathan Peiffer-Smadja

H-Index: 13

Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low-and middle-income …

Research and practice in thrombosis and haemostasis

2023/7/1

An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations

2023/3/1

See List of Professors in Nathan Peiffer-Smadja University(Imperial College London)